Bioventix PLC is a United Kingdom-based biotechnology company. The principal activity of the Company is the development and supply of antibodies. The Company specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drugs of abuse testing. The Company's non-vitamin D business consists of antibodies, NT proBNP (heart failure), testosterone, Free Triiodothyronine (FT3) (thyroid hormone), estradiol, and various drugs, such as tetrahydrocannabinol (THC)/cannabis, and progesterone. The Company offers products for indications, such as thyroid, fertility, oncology, cardiac, vitamin D, drug of abuse, infectious disease and miscellaneous. Its sheep hybridoma technology produces cell lines that secrete SMAs. The Company offers a panel of SMAs to 25-OH D and has various 25-OH D2 and 25-OH D3 specific antibodies. It sells its products through direct sales and through distributors.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Biotechnology & Medical Research - NEC
- Sub-Industry: N/A
- Symbol: LON:BVXP
- CUSIP: N/A
- Web: www.bioventix.com/
- Market Cap: £109.7 million
- Outstanding Shares: 5,073,000
- 50 Day Moving Avg: GBX 1,927.03
- 200 Day Moving Avg: GBX 1,808.59
- 52 Week Range: GBX 975 - GBX 2,200
Sales & Book Value:
- Trailing P/E Ratio: 27.24
- P/E Growth: 0.00
- Annual Revenue: £6.27 million
- Price / Sales: 17.50
- Book Value: GBX 1.58 per share
- Price / Book: 13.69
- EBIDTA: £5.04 million
- Net Margins: 63.34%
- Return on Equity: 48.71%
- Return on Assets: 45.31%
- Average Volume: 4,256 shs.
Frequently Asked Questions for Bioventix PLC (LON:BVXP)
What is Bioventix PLC's stock symbol?
Bioventix PLC trades on the London Stock Exchange (LON) under the ticker symbol "BVXP."
How often does Bioventix PLC pay dividends? What is the dividend yield for Bioventix PLC?
Bioventix PLC announced a dividend on Monday, March 27th. Investors of record on Thursday, April 6th will be given a dividend of GBX 20 per share on Friday, April 21st. This represents a yield of 1.11%. The ex-dividend date is Thursday, April 6th. The official announcement can be viewed at this link. View Bioventix PLC's Dividend History.
When will Bioventix PLC make its next earnings announcement?
Where is Bioventix PLC's stock going? Where will Bioventix PLC's stock price be in 2017?
0 brokerages have issued 1-year target prices for Bioventix PLC's stock. Their predictions range from GBX 1,750 to GBX 1,750. On average, they anticipate Bioventix PLC's share price to reach GBX 1,750 in the next twelve months. View Analyst Ratings for Bioventix PLC.
Who are some of Bioventix PLC's key competitors?
Some companies that are related to Bioventix PLC include Protagonist Therapeutics (PTGX), Arbutus Biopharma Corporation (ABUS), NewLink Genetics Corporation (NLNK), Compugen (CGEN), OncoMed Pharmaceuticals (OMED), Merrimack Pharmaceuticals (MACK), Asterias Biotherapeutics (AST), Asterias Biotherapeutics (AST), Chromadex Corp (CDXC), Threshold Pharmaceuticals (MTEM), Novelion Therapeutics (NVLN), Matinas BioPharma Holdings (MTNB), Pluristem Therapeutics (PSTI), Genocea Biosciences (GNCA), Tissue Regenix Group PLC (TRX), BioLineRx (BLRX), Oramed Pharmaceuticals (ORMP) and CTI BioPharma Corp. (CTIC).
Who are Bioventix PLC's key executives?
Bioventix PLC's management team includes the folowing people:
- P. Harrison, Chief Executive Officer, Director
- Ian J. Nicholson, Non-Executive Chairman of the Board
- Kim S. Tan Ph.D., Director
- T. Turner, Director
- Nick McCooke, Non-Executive Director
How do I buy Bioventix PLC stock?
Shares of Bioventix PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Bioventix PLC's stock price today?
MarketBeat Community Rating for Bioventix PLC (LON BVXP)MarketBeat's community ratings are surveys of what our community members think about Bioventix PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Bioventix PLC stock can currently be purchased for approximately GBX 2,162.50.
Consensus Ratings for Bioventix PLC (LON:BVXP) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||GBX 1,750|
Analysts' Ratings History for Bioventix PLC (LON:BVXP)
(Data available from 8/18/2015 forward)
|5/30/2017||FinnCap||Reiterated Rating||Corporate||GBX 1,750|
Earnings History for Bioventix PLC (LON:BVXP)Earnings History by Quarter for Bioventix PLC (LON BVXP)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Bioventix PLC (LON:BVXP)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History by Quarter for Bioventix PLC (LON BVXP)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Bioventix PLC (LON:BVXP)Insider Trades by Quarter for Bioventix PLC (LON:BVXP)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/18/2016||Ian James Nicholson||Insider||Sell||2,000||GBX 1,300||£26,000|
|10/20/2015||Nicholson,Ian James||Insider||Sell||5,000||GBX 1,115||£55,750|
|4/29/2015||Peter John Harrison||Insider||Sell||53,000||GBX 800||£424,000|
|4/16/2015||Peter John Harrison||Insider||Sell||100,000||GBX 800||£800,000|
Headline Trends for Bioventix PLC (LON:BVXP)
Latest Headlines for Bioventix PLC (LON:BVXP)
Bioventix PLC (BVXP) Chart for Friday, August, 18, 2017